ALPS Group Inc Ordinary Share · ALPS

Exhibit 99.1 Alps Group Inc Announces Shareholder Approval for a Share Consolidation, Share Capital Increase, and Adoption of Second Amended and Restated Memorandum and Articles of Association KUALA LUMPUR, Malaysia, Oct. 30, 2026 (GLOBE NEWSWIRE) - Alps Group Inc (“Alps” or “the Company”) (Nasdaq: ALPS), an integrated biotechnology platform headquartered in Malaysia, today announced that its shareholders approved, in accordance with Cayman Islands law, all of the proposals submitted at the Co…

6-K · 2026-10-30 · 0001493152-26-049433

Exhibit 99.1 SUPPLEMENT TO PROXY STATEMENT OF ALPS GROUP INC DATED OCTOBER 15, 2026 EXTRAORDINARY GENERAL MEETING TO BE HELD ON OCTOBER 30, 2026 9:30 AM MALAYSIAN TIME This supplement (this “ Supplement ”) is being filed by Alps Group Inc, a Cayman Islands exempted company (the “ Company ”) to supplement the Notice and Proxy Statement of the Meeting, dated October 9, 2026 (the “ Proxy ”) and filed with the U.S Securities and Exchange Commission (the “ SEC” ) on October 8, 2026 in connect…

6-K · 2026-10-15 · 0001493152-26-047250

Exhibit 99.1 Alps Group Inc (an exempted company incorporated in the Cayman Islands with limited liability) (NASDAQ: ALPS) NOTICE OF 2026 EXTRAORDINARY GENERAL MEETING to be held on October 21, 2026 (or any adjourned or postponed meeting thereof) NOTICE IS HEREBY GIVEN THAT the 2026 extraordinary general meeting (the “ Meeting ”) of the holders (each a “ Shareholder ”, and, collectively, the “ Shareholders ”) of the shares (the “ Ordinary Shares ”) of Alps Group Inc (the “ Company ”) will be …

6-K · 2026-10-08 · 0001493152-26-046334

Exhibit 99.2 FORM OF PROXY RELATING TO 2026 EXTRAORDINARY GENERAL MEETING OF ALPS GROUP INC (an exempted company incorporated in the Cayman Islands with limited liability, registration number (409916) (NASDAQ: ALPS) This form of proxy relates to the 2026 extraordinary general meeting (“Meeting”) of Alps Group Inc (the “Company”) to be held on Wednesday, 21 October 2026, at 10:00 AM (Malaysia Standard Time) virtually via Zoom conference call using the following access information and at any a…

6-K · 2026-10-08 · 0001493152-26-046334

Exhibit 99.1 Alps Group Inc Reports Fiscal Year 2026 Financial Results and Provides Business Update Revenue Grew 44% to $4.9 Million, Led by Continued Growth Across Cellular Therapy, Medical Testing, Laboratory and Aesthetics Beauty Services, and Healthcare Products Began Trading on the Nasdaq Global Market Under the Ticker Symbol “ALPS” in October 2025, Marking the Company’s Transition to the U.S. Public Markets KUALA LUMPUR, Malaysia - August 7, 2026 - Alps Group Inc (“Alps” or “the Compan…

6-K · 2026-08-07 · 0001493152-26-036587

Exhibit 99.1 Alps Group Inc Launches Patient-Derived Organoid Program to Advance Personalized Cancer Care in Southeast Asia Agreement Marks Company’s Expansion into Precision Oncology Testing, with the Goal of Establishing Malaysia’s First Clinically Validated PDO Platform KUALA LUMPUR, Malaysia - June 23, 2026 - Alps Group Inc (“Alps” or “the Company”) (Nasdaq: ALPS), an integrated biotechnology platform headquartered in Malaysia, today announced its expansion into patient-derived organoid (…

6-K · 2026-06-23 · 0001493152-26-029779